Elevation Oncology Is An Oncology Company Focused On Discovering And Developing Selective Cancer Therapies For Patients With Solid Tumorsthe Company Aims To Address Significant Unmet Medical Needs By Tailoring Treatments To The Unique Characteristics Of Each Patient S Tumor Elevation Oncology Specializes In Differentiated Antibody Drug Conjugatesadcswith Therapeutic Potentialtheir Pipeline Includes Eo 1022A Her3 Adc Currently In Preclinical Developmentdesigned To Meet Emerging Needs In Her3 Expressing Cancersthe Company Plans To Present Preclinical Data On This Candidate At The Aacr Annual Meeting The Leadership Team At Elevation Oncology Includes Experienced Professionals From The Oncology And Pharmaceutical Sectorssuch As Maegan Deegan And Henry Bkoonmdthe Company Is Committed To Advancing Its Innovative Therapies While Evaluating Strategic Options To Enhance Stakeholder Value
